BR0008677A - Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação - Google Patents
Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiaçãoInfo
- Publication number
- BR0008677A BR0008677A BR0008677-0A BR0008677A BR0008677A BR 0008677 A BR0008677 A BR 0008677A BR 0008677 A BR0008677 A BR 0008677A BR 0008677 A BR0008677 A BR 0008677A
- Authority
- BR
- Brazil
- Prior art keywords
- thiazolindolinone
- compound
- severity
- chemotherapy
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9904930.6A GB9904930D0 (en) | 1999-03-04 | 1999-03-04 | Thiazoloindolinone compounds |
| PCT/US2000/005192 WO2000052013A2 (en) | 1999-03-04 | 2000-03-01 | Thiazoloindolinone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0008677A true BR0008677A (pt) | 2002-01-08 |
Family
ID=10848912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0008677-0A BR0008677A (pt) | 1999-03-04 | 2000-03-01 | Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1159280A2 (xx) |
| JP (1) | JP2003532620A (xx) |
| KR (1) | KR20020005606A (xx) |
| CN (1) | CN1355807A (xx) |
| AU (1) | AU3611000A (xx) |
| BR (1) | BR0008677A (xx) |
| CA (1) | CA2361580A1 (xx) |
| CZ (1) | CZ20013187A3 (xx) |
| GB (1) | GB9904930D0 (xx) |
| HK (1) | HK1041692A1 (xx) |
| HU (1) | HUP0200376A3 (xx) |
| IL (1) | IL144808A0 (xx) |
| MX (1) | MXPA01008910A (xx) |
| NO (1) | NO20014262L (xx) |
| PL (1) | PL351476A1 (xx) |
| TR (1) | TR200102557T2 (xx) |
| WO (1) | WO2000052013A2 (xx) |
| ZA (1) | ZA200106826B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| JP2007519757A (ja) * | 2004-12-01 | 2007-07-19 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | ピメクロリマスの調製方法 |
| UA103319C2 (xx) * | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Сполуки бензенсульфонамідтіазолу та -оксазолу$соединения бензенсульфонамидтиазола и -оксазола |
| JP4761000B1 (ja) * | 2010-11-08 | 2011-08-31 | 小野薬品工業株式会社 | 手足症候群の予防および／または治療剤 |
| ES2604705T3 (es) | 2010-03-31 | 2017-03-08 | Ono Pharmaceutical Co., Ltd. | Agente preventivo y/o remedio para el síndrome mano-pie |
| CA3085013A1 (en) | 2017-12-13 | 2019-06-20 | Onquality Pharmaceuticals China Ltd. | A method for preventing or treating egfr-inhibition associated diseases |
| CN114028568A (zh) | 2018-04-16 | 2022-02-11 | 上海岸阔医药科技有限公司 | 预防或治疗肿瘤疗法副作用的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998050356A1 (en) * | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
1999
- 1999-03-04 GB GBGB9904930.6A patent/GB9904930D0/en not_active Ceased
-
2000
- 2000-03-01 KR KR1020017011094A patent/KR20020005606A/ko not_active Application Discontinuation
- 2000-03-01 BR BR0008677-0A patent/BR0008677A/pt not_active Application Discontinuation
- 2000-03-01 CA CA002361580A patent/CA2361580A1/en not_active Abandoned
- 2000-03-01 PL PL00351476A patent/PL351476A1/xx not_active Application Discontinuation
- 2000-03-01 HU HU0200376A patent/HUP0200376A3/hu unknown
- 2000-03-01 EP EP00914762A patent/EP1159280A2/en not_active Withdrawn
- 2000-03-01 CZ CZ20013187A patent/CZ20013187A3/cs unknown
- 2000-03-01 IL IL14480800A patent/IL144808A0/xx unknown
- 2000-03-01 CN CN00804616A patent/CN1355807A/zh active Pending
- 2000-03-01 TR TR2001/02557T patent/TR200102557T2/xx unknown
- 2000-03-01 JP JP2000602239A patent/JP2003532620A/ja active Pending
- 2000-03-01 AU AU36110/00A patent/AU3611000A/en not_active Abandoned
- 2000-03-01 MX MXPA01008910A patent/MXPA01008910A/es not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005192 patent/WO2000052013A2/en not_active Application Discontinuation
-
2001
- 2001-08-17 ZA ZA200106826A patent/ZA200106826B/en unknown
- 2001-09-03 NO NO20014262A patent/NO20014262L/no not_active Application Discontinuation
-
2002
- 2002-05-02 HK HK02103309.8A patent/HK1041692A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20013187A3 (cs) | 2002-02-13 |
| WO2000052013A3 (en) | 2000-12-28 |
| MXPA01008910A (es) | 2002-03-27 |
| CN1355807A (zh) | 2002-06-26 |
| HUP0200376A3 (en) | 2003-07-28 |
| PL351476A1 (en) | 2003-04-22 |
| IL144808A0 (en) | 2002-06-30 |
| NO20014262D0 (no) | 2001-09-03 |
| NO20014262L (no) | 2001-10-30 |
| HUP0200376A2 (en) | 2002-06-29 |
| TR200102557T2 (tr) | 2007-01-22 |
| KR20020005606A (ko) | 2002-01-17 |
| CA2361580A1 (en) | 2000-09-08 |
| JP2003532620A (ja) | 2003-11-05 |
| AU3611000A (en) | 2000-09-21 |
| HK1041692A1 (zh) | 2002-07-19 |
| GB9904930D0 (en) | 1999-04-28 |
| ZA200106826B (en) | 2003-02-25 |
| EP1159280A2 (en) | 2001-12-05 |
| WO2000052013A2 (en) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| SE9904505D0 (sv) | Novel compounds | |
| BR0008840A (pt) | Derivados de camptotecina tendo atividade antitumoral | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0211801A (pt) | Derivados de 7h-pirrolo[2,3-d]pirimidina | |
| BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
| PT1119543E (pt) | N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y | |
| BR0317717A (pt) | Composto, composição farmacêutica, uso de um composto, método para tratar um humano sofrendo de uma doença, e, processo para a preparação de um composto | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| PT1200412E (pt) | Agentes anti-proliferativos de imidazole | |
| MXPA04012965A (es) | Inhibidores virales. | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| SE9802208D0 (sv) | Novel compounds | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| BRPI0411503A (pt) | composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| BR0311491A (pt) | Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero | |
| BR0008677A (pt) | Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| SE9802209D0 (sv) | Novel compounds | |
| BR0011880A (pt) | Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica | |
| NO20006547L (no) | Salter av paroxetine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |